By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Accuray Incorporated

Accuray Incorporated (ARAY)

NASDAQ Currency in USD
$381.00
+$6.99
+1.87%
Last Update: 18 Jul 2026, 14:26
$39.15bn
Market Cap
-1.03k
P/E Ratio (TTM)
Forward Dividend Yield
$252.66-$531.18
52 Week Range

ARAY Stock Price Chart

Explore Accuray Incorporated interactive price chart. Choose custom timeframes to analyze ARAY price movements and trends.

ARAY Company Profile

Discover essential business fundamentals and corporate details for Accuray Incorporated (ARAY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

8 Feb 2007

Employees

987.00

CEO

Stephen R. LaNeve

Description

Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver highly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.

ARAY Financial Timeline

Browse a chronological timeline of Accuray Incorporated corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 19 Aug 2026

EPS estimate is -$0.03, while revenue estimate is $105.30m.

Earnings released on 6 May 2026

EPS came in at -$0.09 falling short of the estimated -$0.05 by -80.00%, while revenue for the quarter reached $104.85m , missing expectations by -6.30%.

Earnings released on 4 Feb 2026

EPS came in at -$0.11 falling short of the estimated -$0.11 by -2.23%, while revenue for the quarter reached $102.24m , beating expectations by +1.37%.

Earnings released on 5 Nov 2025

EPS came in at -$0.18 falling short of the estimated -$0.01 by -1.70k%, while revenue for the quarter reached $93.94m , missing expectations by -23.56%.

Earnings released on 13 Aug 2025

EPS came in at $0.01 falling short of the estimated $0.03 by -65.63%, while revenue for the quarter reached $127.54m , beating expectations by +37.22%.

Earnings released on 30 Apr 2025

EPS came in at -$0.01 surpassing the estimated -$0.05 by +80.00%, while revenue for the quarter reached $113.24m , missing expectations by -8.51%.

Earnings released on 5 Feb 2025

EPS came in at $0.02 surpassing the estimated -$0.01 by +300.00%, while revenue for the quarter reached $116.17m , beating expectations by +5.27%.

Earnings released on 6 Nov 2024

EPS came in at -$0.04 falling short of the estimated -$0.03 by -24.53%, while revenue for the quarter reached $101.55m , beating expectations by +4.10%.

Earnings released on 14 Aug 2024

EPS came in at $0.03 falling short of the estimated $0.04 by -25.00%, while revenue for the quarter reached $134.29m , beating expectations by +10.52%.

Earnings released on 1 May 2024

EPS came in at -$0.06 falling short of the estimated -$0.01 by -380.00%, while revenue for the quarter reached $101.13m , missing expectations by -16.77%.

Earnings released on 31 Jan 2024

EPS came in at -$0.10 falling short of the estimated -$0.07 by -42.86%, while revenue for the quarter reached $107.24m , beating expectations by +0.53%.

Earnings released on 7 Nov 2023

EPS came in at -$0.03 falling short of the estimated -$0.02 by -39.99%, while revenue for the quarter reached $103.89m , beating expectations by +6.42%.

Earnings released on 9 Aug 2023

EPS came in at -$0.03 falling short of the estimated -$0.01 by -400.00%, while revenue for the quarter reached $118.29m , missing expectations by -2.83%.

Earnings released on 26 Apr 2023

EPS came in at $0.01 surpassing the estimated $0.00 by +185.71%, while revenue for the quarter reached $118.06m , missing expectations by -3.11%.

Earnings released on 1 Feb 2023

EPS came in at -$0.02 falling short of the estimated -$0.02 by -25.00%, while revenue for the quarter reached $114.76m , beating expectations by +7.22%.

Earnings released on 2 Nov 2022

EPS came in at -$0.06 falling short of the estimated -$0.02 by -172.73%, while revenue for the quarter reached $96.49m , missing expectations by -3.45%.

Earnings released on 10 Aug 2022

EPS came in at -$0.04 surpassing the estimated -$0.06 by +33.33%, while revenue for the quarter reached $110.02m , beating expectations by +4.47%.

Earnings released on 27 Apr 2022

EPS came in at -$0.01 surpassing the estimated -$0.06 by +83.33%, while revenue for the quarter reached $96.17m , beating expectations by +0.13%.

Earnings released on 26 Jan 2022

EPS came in at $0.00 , while revenue for the quarter reached $116.28m , beating expectations by +12.54%.

Earnings released on 3 Nov 2021

EPS came in at -$0.01 falling short of the estimated -$0.01 by -75.13%, while revenue for the quarter reached $107.44m , beating expectations by +21.42%.

Earnings released on 11 Aug 2021

EPS came in at -$0.01 falling short of the estimated -$0.01 by -54.56%, while revenue for the quarter reached $110.94m , meeting expectations.

ARAY Stock Performance

Access detailed ARAY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run